SEC Tracker
Get the app

Balance Labs BLNC

Balance Labs Q3 FY24: net loss $193K; diluted EPS −$0.01

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Balance Labs reported for Q3 FY24, the quarter ended Sep 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Net income−$193KAgainst −$69K in Q3 FY2310-Q income statement, on EDGAR
  2. Diluted EPS−$0.01Against $0.00 in Q3 FY2310-Q income statement, on EDGAR
  3. Cash and cash equivalents$30K−79% from $146K in Q3 FY23Cash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
  4. Cash from operations−$43KAgainst −$37K in Q3 FY2310-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Balance Labs files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8742 and related industry codes: the same peer list as the financial tables.

  1. Yellowstone Group YSGL
  2. Bodhi Tree Biotechnology BDTB
  3. Vertical Data VDTA public float $2M, Mar 31, 2025, over 18 months old
  4. 1847 Holdings LBRA public float $2M, Jun 30, 2025
  5. Greenpro Capital GRNQ public float $8M, Jun 30, 2025